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Introduction
Fusiform aneurysms are non-saccular dilations that involve the entire vessel wall in a given arterial segment, for a short distance. In the presence of a larger, circumferential length involving >180 of the vessel wall, they are called cylindrical or circumferential aneurysms. 1 These aneurysms are rarer; however, their diagnosis has increased in the last few years and may account for 3-13% of all the most commonly found intracranial aneurysms in the posterior circulation. 2 Fusiform aneurysms have a multivariate physiopathogenesis, so they may originate following dissection; atherosclerosis; collagen and elastin disorders; infection; or rarely, from neoplastic infiltration, as well as due to unknown factors. This type of aneurysm may present clinically in several forms, ranging from meningeal hemorrhage, intracerebral hemorrhage, neurological deficit from cerebral ischemia; to dizziness, cranial nerve deficit from mass effect, or incidental findings. 3 There are few reports on the treatment of fusiform aneurysms. When these aneurysms involve lateral arterial branches or perforating vessels that must be kept pervious, the therapeutic strategy is difficult to define and a particular challenge for neuroradiologists and neurosurgeons.
Case reports

Case 1
A 27-year-old female patient presented with highly intense headache. Computed tomography (CT) scan evidenced a hypercaptant and regular image, next to the brain stem. Figure 1(a) shows the lateral left internal carotid artery angiography, without the posterior communicating artery. Angiography and 3-dimensional (3D) angiography of the vertebral basilar system (Figure 1(b) , (c) and (d)) shows a large, circumferential, fusiform aneurysmatic dilation of segments P2 and P3 of the left posterior cerebral artery, which was 18 mm long and measured 9 mmÂ 9.5 mm at its largest diameter. Treatment was decided upon: A vascular reconstruction technique with the associated use of a self-expandable stent and flow-diverter device, at different surgical times. 
Case 2
A 19-year-old male patient presented with clinical conditions of sudden headache, vertigo with loss of balance, and total right hemiparesis. Symptoms receded as days went by. A magnetic resonance imaging (MRI) exam evidenced an image suggesting a partially thrombosed aneurysm of the low basilar artery, with a hypersignal of acute ischemia of the brain stem (Figure 2(a) ). Angiography was done in both the internal carotid and in the lateral view, without good posterior communication (Figure 2 (b) and (c)). Both the angiography and 3D angiography gave evidence of a partially thrombosed, large and complex circumferential fusiform aneurysm of the low basilar artery, which was 22 mm long and 11 mmÂ 11 mm at its larger diameter, with involvement of two vertebral arteries, as well as the anterior and inferior cerebellar arteries (AICA) (Figure 2(d) , (e) and (f)). Second surgical procedure. This was done 3 months later, keeping double antiplatelet therapy. We used general anesthesia. A long 6F IVA introducer (Balt, Montmorency, France) was positioned into the V2 segment of the right vertebral artery. A Fargo Max 6F catheter (Balt, Montmorency, France) was positioned into the V4 segment of the right vertebral artery. Angiographic control evidenced aneurysm sub-occlusion with partial arterial reconstruction. A Vasco 21 microcatheter (Balt, Montmorency, France) was positioned distally into the P4 segment of the left posterior cerebral artery, with the aid of Traxcess 14
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Interventional Neuroradiology 22(5) microguidewire (Microinvention, Tustin, CA, USA), and the flow-diverter device SILK 3.5 mmÂ 30 mm (Balt, Montmorency, France) was positioned and implanted overlapping the two LEOþ stents (Balt, Montmorency, France). Angiographic control showed there was no enwrapping of the aneurysm for the full length, so we chose to place a second telescoped flowdiverter device, SILK 3.0 mmÂ 20 mm (Balt, Montmorency, France), which covered the aneurysm for the full length and the image, without bone subtraction, demonstrated good visualization of the overlapping stents, LEOþ e SILK (Figure 2(i) ). Angiographic controls at 6 and 12 months showed the basilar artery reconstruction and full elimination of the aneurysm (Figure 2 (j) and (k)). Arterial flow through the right anterior inferior cerebellar artery was kept; however, contralateral AICA was occluded, with its territory being supplied by pial anastomosis of the PICA, without any ischemic event observed clinically or by control MRI. The patient progressed without any complications.
Discussion
Fusiform aneurysms, particularly the circumferential ones involving the arterial wall in > 180 , with arterial branches or perforating vessels to the brain stem and that are symptomatic, are still a challenge.
Treatment of aneurysms of the P2 and P3 segments of the posterior distal cerebral artery is challenging for performing the surgical technique due to: The difficult access, the involvement of perforating vessels of the brain stem, the extensive anastomotic vascular network of that region, as well as the risk of injury of cranial nerves (nerves III and IV); 4-6 as well as the circumferential fusiform aneurysms of the basilar artery involving its branches, with variable clinical symptoms related to its course, due to the compressive effect, ischemia or rupture. Existing data indicate that nonsaccular vertebrobasilar aneurysms have a poor natural history, as well as that their surgical treatment has poor results. 2, 7 Fusiform aneurysms of the vertebrobasilar junction and basilar artery are lesions in need of a complex surgical approach, and are difficult for the performance of arterial bypass or arterial wall reconstruction. Endovascular treatment of this type of lesion with the use of stents and microcoils has been described for long sections, even with the risk of occlusion of the perforating vessels, which is also common with this surgical procedure. 8 This combined technique using stents and microcoils may significantly reduce aneurysm recurrences as seen by angiographic follow-up in the long term; however, a higher association with increased morbidity and fatal complications was observed, when compared with the use of microcoils without stents. 9 With the evolution of intracranial stents, lowporosity, self-expandable stents with better navigability into intracranial arteries started to be used in fusiform aneurysms of the basilar artery, reaching remarkable results with aneurysm healing and arterial remodeling. 10, 11 In-vitro evaluation has shown that aneurysms of the basilar artery may be treated by redirecting the flow vortex in the arterial lumen; and these changes may create a favorable environment for aneurysm thrombosis, without the need of using microcoils. 12 Intracranial stents have anatomical action by the arterial reconstruction, functional action with the modification of the flow within the aneurysm, and a biological action with neointimal growth over the aneurysm neck. 13 Fusiform aneurysms located in the P2 segment of the posterior cerebral artery have been treated with the endovascular technique, through occlusion of the aneurysmatic sac and the proximal portion of the P2A segment of the posterior cerebral artery, with the use of platinum microcoils following occlusion testing. 14 The treatment of fusiform aneurysms, using exclusively self-expandable stents or balloon-expandable stents, has been described; however, there were poor results and partial aneurysmatic occlusion on the long-term angiographic follow-up. [15] [16] [17] Another technique in endovascular treatment of fusiform aneurysms was the use of the self-expandable stent with a balloon catheter expanded at the time of the microcoil placement, to prevent prolapse within the vessel; however, this may increase the risk of complications with the temporary occlusion of arterial branches and perforating vessels. 18, 19 The exclusive use of the self-expandable stent was depicted as an option for fusiform aneurysms of the P2 segment of the distal posterior cerebral artery. 20 The use of a stent may minimize cerebral perfusion in the territory of perforating vessels, with an increased risk of cerebral infarction when placed over perforating arteries. 21 Nevertheless, the use of the single stent in intracranial arteries is, in general, considered as safe with regard to occlusion of the perforating vessels, as this type of device may reduce flow through the perforating arteries by as much as 15%. 22 In-vitro studies have shown that the use of three lowprofile, telescoped stents, or flow-diverter stents, reduces flow rates through the perforating vessels by as much as 46%; however, the risk of infarction or ischemia occurs when there is a higher than 50% reduction in the perforating vessel flow. 23, 24 In the post-procedural analysis of diffusion-weighted magnetic resonance imaging (DWI) of aneurysms treated with a flow-diverter implant at 24 h, 48 h and after 3 months, showed that a greater quantity of ischemic and asymptomatic micro lesions (DWI spots) were noticed distal to the managed arterial segment (86%), which revealed an increase in embolic events with the use of these devices, which may be related to their mechanical properties or their handling during the procedure, but that have not been shown to be statistically significant in a multivariable analysis. 25 
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Interventional Neuroradiology 22 (5) The endovascular technique with the approach in different stages of the same aneurysm is already being described as a more efficacious technique for the treatment of aneurysms with the need of using stent in patients not on antiplatelet aggregation drugs, or even when there is the need of stabilizing the stent with its endothelialization and adherence to the arterial endothelium, in wide-necked aneurysms. 15, 26 More recently, the development of flow-diverter devices is an alternative to the treatment of wide and giant aneurysms, wide-necked aneurysms, as well as relapsing aneurysms; with the aim of achieving a quick flow reduction that, in its turn, leads to aneurysm sac thrombosis, as shown in animal experiments. 27 A recent multicenter report shows major interest in the use of flow-diverter devices for the treatment of intracranial aneurysms, mainly the giant ones and fusiform aneurysms; however, there was a high complication rate in 21.5% of the patients, which may be related to the learning curve with the novel method. Most of these complications occurred in complex, previously non-treatable aneurysms of the posterior circulation. 28 The hemodynamic change within the aneurysmatic sac, as well as thrombosis, have been described as a cause of fatal aneurysm rupture following the implant of flow-diverter devices. 29 Thrombosis occurring within the aneurysmatic sac may cause inflammation of the perianeurysmal brain tissue, with symptomatic worsening after implantation of flow-diverter stents. 30 After a flow diverter implant, occlusion of lateral branches with an estimated diameter of 0.5-1 mm may be immediate or occur at long term, and may be or not associated to neurological deficit. 31 The use of flow-diverter devices was already described for treating circumferential fusiform aneurysms of the posterior circulation; however, what causes a certain confusion in results is that in the two described cases, aneurysms were previously treated with microcoils and/or self-expandable stent, without aneurysm thrombosis having occurred, and so it was decided to use the flow diverter. 32 Currently, there seems to be a trend to use flow-diverter devices as the treatment of choice for aneurysms defined as complex, such the fusiform, circumferential and giant aneurisms of the posterior circulation, even with the risk of fatal rupture or occlusion of lateral vessels with ischemic events. 29 In a multicenter experiment, a trend was shown towards the use of flow diverters in giant, complex, and fusiform aneurysms; with a technical complication rate in 21.5% of the cases. This rate was probably also related to the learning curve of the relatively novel method; in addition, complications occurred more frequently in complex aneurysms of the posterior circulation, considered as non-treatable until recently. However, the occlusion rate in early angiographic controls at 3 months was shown to be high in 85% of the aneurysms. 28 In the two cases presented here, aneurysms were fusiform and circumferential, both with the potential involvement of perforating vessels to the brain stem, with the aneurysm of the basilar artery being even more complex, due to the involvement of two vertebral arteries and the AICA, making still more difficult the therapeutic strategy. The endovascular treatment option with the associated use of the self-expandable stent, LEOþ (Balt, Montmorency, France), and the flow-diverter device, SILK (Balt, Montmorency, France), at different surgical times starting with the implant of that self-expandable LEOþ (Balt, Montmorency, France) stent, and waiting for a time period between 3 and 4 weeks later for the performance of a second procedure for the overlapping or telescoped implant of the SILK flow-diverter device (Balt, Montmorency, France) was chosen for the following reasons:
1. To prevent migration of the self-expandable stent to within the aneurysm when passing the microguide, microcatheter or even the flow-diverter device; 2. To wait 3-4 weeks for the endothelialization of the self-expandable stent, making handling it safer to implant SILK (Balt, Montmorency, France) at a second surgical time; 3. To provide a potential slow and partial thrombosis of the aneurysmatic sac, even before the SILK (Balt, Montmorency, France) implant, minimizing the risk of fatal aneurysm rupture; 4. To provide partial arterial reconstruction, with the possibility of pial arterial anastomosis emergence in the event of involvement with occlusion of the lateral or distal arterial branches before implantation of SILK (Balt, Montmorency, France); and 5. To improve accuracy in the choice of the flow diverter device size, providing improved adherence to the proximal and distal arterial walls, with improved anchorage of the same, since the stent contact surface decreases in circumferential fusiform aneurysms and may cause greater shrinkage of the flow diverter.
Conclusions
Treatment of circumferential fusiform aneurysms of the posterior circulation is still a big challenge for neurosurgeons and neuroradiologists. Arterial reconstruction with the use of flow-diverter devices seemed to be a good option for the treatment of this type of aneurysm; however, a concern about occlusion of the lateral arterial branches and perforating vessels still exists, with the risk of neurological deficit and death due to fatal aneurysm rupture. Due to the complexity of most of these lesions, the possibility of treating them with a technique combining the use of a self-expandable stent and flowdiverter device, overlapping or telescoped, at different surgical times with a 3-4 week time interval, may reduce the risk of morbidity and mortality, as well as the risk of technical failure. The present technique was shown to be feasible; however, a greater number of cases would be required, as well as a long-term angiographic follow-up, in order to define the sustained feasibility of the technique.
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